Cargando…

Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient

Piperacillin–tazobactam is one of the most common causes of drug‐induced immune hemolytic anemia (DIIHA) and is frequently utilized, especially in patients with cystic fibrosis (CF). Here, we report a case of life‐threatening piperacillin–tazobactam‐associated DIIHA in a 30‐year‐old woman with CF an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerkhoff, Andrew D., Patrick, Lauren, Cornett, Patricia, Kleinhenz, Mary‐Ellen, Brondfield, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715418/
https://www.ncbi.nlm.nih.gov/pubmed/29225856
http://dx.doi.org/10.1002/ccr3.1256
_version_ 1783283763400146944
author Kerkhoff, Andrew D.
Patrick, Lauren
Cornett, Patricia
Kleinhenz, Mary‐Ellen
Brondfield, Sam
author_facet Kerkhoff, Andrew D.
Patrick, Lauren
Cornett, Patricia
Kleinhenz, Mary‐Ellen
Brondfield, Sam
author_sort Kerkhoff, Andrew D.
collection PubMed
description Piperacillin–tazobactam is one of the most common causes of drug‐induced immune hemolytic anemia (DIIHA) and is frequently utilized, especially in patients with cystic fibrosis (CF). Here, we report a case of life‐threatening piperacillin–tazobactam‐associated DIIHA in a 30‐year‐old woman with CF and propose management recommendations for piperacillin–tazobactam‐associated DIIHA in CF patients.
format Online
Article
Text
id pubmed-5715418
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57154182017-12-08 Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient Kerkhoff, Andrew D. Patrick, Lauren Cornett, Patricia Kleinhenz, Mary‐Ellen Brondfield, Sam Clin Case Rep Case Reports Piperacillin–tazobactam is one of the most common causes of drug‐induced immune hemolytic anemia (DIIHA) and is frequently utilized, especially in patients with cystic fibrosis (CF). Here, we report a case of life‐threatening piperacillin–tazobactam‐associated DIIHA in a 30‐year‐old woman with CF and propose management recommendations for piperacillin–tazobactam‐associated DIIHA in CF patients. John Wiley and Sons Inc. 2017-11-02 /pmc/articles/PMC5715418/ /pubmed/29225856 http://dx.doi.org/10.1002/ccr3.1256 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Kerkhoff, Andrew D.
Patrick, Lauren
Cornett, Patricia
Kleinhenz, Mary‐Ellen
Brondfield, Sam
Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
title Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
title_full Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
title_fullStr Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
title_full_unstemmed Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
title_short Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
title_sort severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715418/
https://www.ncbi.nlm.nih.gov/pubmed/29225856
http://dx.doi.org/10.1002/ccr3.1256
work_keys_str_mv AT kerkhoffandrewd severepiperacillintazobactaminducedhemolysisinacysticfibrosispatient
AT patricklauren severepiperacillintazobactaminducedhemolysisinacysticfibrosispatient
AT cornettpatricia severepiperacillintazobactaminducedhemolysisinacysticfibrosispatient
AT kleinhenzmaryellen severepiperacillintazobactaminducedhemolysisinacysticfibrosispatient
AT brondfieldsam severepiperacillintazobactaminducedhemolysisinacysticfibrosispatient